Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis

Abstract

Background Tuberculosis (TB) is the second most common cause of death due to a single infectious agent worldwide after COVID-19. Up to 15% of the cases are extrapulmonary, and if it is located in the central nervous system (CNS-TB), it presents high morbidity and mortality. Still, the global epidemiology of CNS-TB remains unknown. Aim To estimate the global prevalence and incidence of CNS-TB based on the available literature. Methods We systematically searched in MEDLINE, Cochrane Central, Scopus, and LILACS databases (April 2020) and included observational studies evaluating the epidemiology of CNS-TB. Two independent researchers selected and assessed the quality of the studies and extracted relevant data. We performed random-effects model meta-analysis of proportions to estimate the pooled prevalence. The protocol of this study was registered in PROSPERO (CRD 42018103946). Results We included 53 studies from 28 countries, representing 12,621 patients with CNS-TB. The prevalence of CNS-TB was 2 per 100,000 inhabitants. According to the clinical setting, the prevalence of CNS-TB represented the 13.91% of all cases of meningitis and 4.55% of all cases of TB. The mortality was calculated by tuberculous meningitis due to the lack of data of other presentation, and it rose up to 42.12% in hospitalized patients. The burden of countries’ TB, Human Development Index (HDI), and the prevalence of HIV were the most important prevalence moderators, especially in patients with TB. No data on incidence were found. Conclusion The prevalence and mortality of CNS-TB remain high, and TB meningitis is the most frequent presentation. The highest prevalence was reported in developing countries, and its main moderators were the countries’ HDI and HIV infection. Our study was limited by high heterogeneity, risk of bias, and potential data under registration from developing countries. The integration of CNS-TB early detection and management into national TB programs and population-based studies from developing countries are needed for better global estimation and response. Supplementary Information The online version contains supplementary material available at 10.1007/s00415-022-11052-8.

Disseminated tuberculosis in an immunocompetent woman from the Himalayan region of Nepal: A case report

“…Central nervous system TB (CNS TB) is one of the most challenging clinical diagnoses, with a prevalence of 4.55% of all cases of TB. The spectrum of CNS TB includes TB meningitis, tuberculoma, and spinal arachnoiditis, where TB meningitis is the most predominant form 10 . Small tuberculous lesions known as Rich's foci, formed in the cerebral cortex, cerebral parenchyma, or spinal cord, may remain dormant for several years.…”

Paroxysmal sympathetic hyperactivity syndrome in tuberculous meningitis with paradoxical reaction

“…Tuberculosis remains a significant public health issue around the world, in which Indonesia is a one of the most significant contributors to the global burden [9] . Tuberculosis of brain, such as tuberculous meningitis and tuberculoma, is the most lethal form of tuberculosis with up to 40 % mortality [10] , [11] . The primary management goals are to reduce intracranial pressure and improve cerebral perfusion, while also to eradicate the bacteria and to lessen intracerebral inflammation [12] .…”

Tuberculous meningomyelitis: Report of a case

“…Central nervous system tuberculosis (CNS-TB) is one of the most challenging clinical diagnosis, with high morbidity and mortality. Estimated global prevalence of CNS-TB is 2/100,000 inhabitants, and mortality is as high as 42% in hospitalized patients [1].…”